Preeclampsia-Associated Cardiovascular Risk Factors 6 Months and 2 Years After Pregnancy: The P4 Study

Increased cardiovascular risk following preeclampsia is well established and there are signs of early cardiovascular aging 6 months postpartum. This study assessed whether blood pressure (BP) and other cardiovascular measures are abnormal 2 years postpartum in the same cohort to determine ongoing ri...

Full description

Saved in:
Bibliographic Details
Published inHypertension (Dallas, Tex. 1979) Vol. 81; no. 4; pp. 851 - 860
Main Authors Henry, Amanda, Mangos, George, Roberts, Lynne M, Brown, Mark A, Pettit, Franziska, O'Sullivan, Anthony J, Crowley, Rose, Youssef, George, Davis, Gregory K
Format Journal Article
LanguageEnglish
Published United States Lippincott Williams & Wilkins 01.04.2024
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Increased cardiovascular risk following preeclampsia is well established and there are signs of early cardiovascular aging 6 months postpartum. This study assessed whether blood pressure (BP) and other cardiovascular measures are abnormal 2 years postpartum in the same cohort to determine ongoing risk markers. Six months and 2 years postpartum, BP was measured using sphygmomanometry, 24-hour ambulatory BP monitoring, and noninvasive central BP. Anthropometric measures, blood, and urine biochemistry were performed. Cross-sectional comparisons between preeclampsia and normotensive pregnancy (NP) groups and longitudinal comparisons within each group were made at 6 months and 2 years. Two years postpartum, 129 NP, and 52 preeclampsia women were studied who also had 6 months measures. At both time points, preeclampsia group had significantly higher BP (office BP 2 years, 112±12/72±8 versus 104±9/67±7 mm Hg NP; [ <0.001]; mean ambulatory BP monitoring 116±9/73±8 versus 106±8/67±6 mm Hg NP; [ <0.001]). No significant BP changes noted 6 months to 2 years within either group. Office BP thresholds of 140 mm Hg systolic and 90 mm Hg diastolic classified 2% preeclampsia and 0% NP at 2 years. American Heart Association 2017 criteria (above normal, >120/80 mm Hg) classified 25% versus 8% ( <0.002), as did our reference range threshold of 122/79 mm Hg. American Heart Association criteria classified 60% post-preeclampsia versus 16% after NP with above-normal ambulatory BP monitoring ( <0.001). Other cardiovascular risk markers more common 2 years post-preeclampsia included higher body mass index (median 26.6 versus 23.1, =0.003) and insulin resistance. After preeclampsia, women have significantly higher BP 6 months and 2 years postpartum, and have higher body mass index and insulin-resistance scores, increasing their future cardiovascular risk. Regular cardiovascular risk screening should be implemented for all who have experienced preeclampsia.
AbstractList BACKGROUND: Increased cardiovascular risk following preeclampsia is well established and there are signs of early cardiovascular aging 6 months postpartum. This study assessed whether blood pressure (BP) and other cardiovascular measures are abnormal 2 years postpartum in the same cohort to determine ongoing risk markers. METHODS: Six months and 2 years postpartum, BP was measured using sphygmomanometry, 24-hour ambulatory BP monitoring, and noninvasive central BP. Anthropometric measures, blood, and urine biochemistry were performed. Cross-sectional comparisons between preeclampsia and normotensive pregnancy (NP) groups and longitudinal comparisons within each group were made at 6 months and 2 years. RESULTS: Two years postpartum, 129 NP, and 52 preeclampsia women were studied who also had 6 months measures. At both time points, preeclampsia group had significantly higher BP (office BP 2 years, 112±12/72±8 versus 104±9/67±7 mm Hg NP; [ P <0.001]; mean ambulatory BP monitoring 116±9/73±8 versus 106±8/67±6 mm Hg NP; [ P <0.001]). No significant BP changes noted 6 months to 2 years within either group. Office BP thresholds of 140 mm Hg systolic and 90 mm Hg diastolic classified 2% preeclampsia and 0% NP at 2 years. American Heart Association 2017 criteria (above normal, >120/80 mm Hg) classified 25% versus 8% ( P <0.002), as did our reference range threshold of 122/79 mm Hg. American Heart Association criteria classified 60% post-preeclampsia versus 16% after NP with above-normal ambulatory BP monitoring ( P <0.001). Other cardiovascular risk markers more common 2 years post-preeclampsia included higher body mass index (median 26.6 versus 23.1, P =0.003) and insulin resistance. CONCLUSIONS: After preeclampsia, women have significantly higher BP 6 months and 2 years postpartum, and have higher body mass index and insulin-resistance scores, increasing their future cardiovascular risk. Regular cardiovascular risk screening should be implemented for all who have experienced preeclampsia.
Increased cardiovascular risk following preeclampsia is well established and there are signs of early cardiovascular aging 6 months postpartum. This study assessed whether blood pressure (BP) and other cardiovascular measures are abnormal 2 years postpartum in the same cohort to determine ongoing risk markers. Six months and 2 years postpartum, BP was measured using sphygmomanometry, 24-hour ambulatory BP monitoring, and noninvasive central BP. Anthropometric measures, blood, and urine biochemistry were performed. Cross-sectional comparisons between preeclampsia and normotensive pregnancy (NP) groups and longitudinal comparisons within each group were made at 6 months and 2 years. Two years postpartum, 129 NP, and 52 preeclampsia women were studied who also had 6 months measures. At both time points, preeclampsia group had significantly higher BP (office BP 2 years, 112±12/72±8 versus 104±9/67±7 mm Hg NP; [ <0.001]; mean ambulatory BP monitoring 116±9/73±8 versus 106±8/67±6 mm Hg NP; [ <0.001]). No significant BP changes noted 6 months to 2 years within either group. Office BP thresholds of 140 mm Hg systolic and 90 mm Hg diastolic classified 2% preeclampsia and 0% NP at 2 years. American Heart Association 2017 criteria (above normal, >120/80 mm Hg) classified 25% versus 8% ( <0.002), as did our reference range threshold of 122/79 mm Hg. American Heart Association criteria classified 60% post-preeclampsia versus 16% after NP with above-normal ambulatory BP monitoring ( <0.001). Other cardiovascular risk markers more common 2 years post-preeclampsia included higher body mass index (median 26.6 versus 23.1, =0.003) and insulin resistance. After preeclampsia, women have significantly higher BP 6 months and 2 years postpartum, and have higher body mass index and insulin-resistance scores, increasing their future cardiovascular risk. Regular cardiovascular risk screening should be implemented for all who have experienced preeclampsia.
BACKGROUNDIncreased cardiovascular risk following preeclampsia is well established and there are signs of early cardiovascular aging 6 months postpartum. This study assessed whether blood pressure (BP) and other cardiovascular measures are abnormal 2 years postpartum in the same cohort to determine ongoing risk markers.METHODSSix months and 2 years postpartum, BP was measured using sphygmomanometry, 24-hour ambulatory BP monitoring, and noninvasive central BP. Anthropometric measures, blood, and urine biochemistry were performed. Cross-sectional comparisons between preeclampsia and normotensive pregnancy (NP) groups and longitudinal comparisons within each group were made at 6 months and 2 years.RESULTSTwo years postpartum, 129 NP, and 52 preeclampsia women were studied who also had 6 months measures. At both time points, preeclampsia group had significantly higher BP (office BP 2 years, 112±12/72±8 versus 104±9/67±7 mm Hg NP; [P<0.001]; mean ambulatory BP monitoring 116±9/73±8 versus 106±8/67±6 mm Hg NP; [P<0.001]). No significant BP changes noted 6 months to 2 years within either group. Office BP thresholds of 140 mm Hg systolic and 90 mm Hg diastolic classified 2% preeclampsia and 0% NP at 2 years. American Heart Association 2017 criteria (above normal, >120/80 mm Hg) classified 25% versus 8% (P<0.002), as did our reference range threshold of 122/79 mm Hg. American Heart Association criteria classified 60% post-preeclampsia versus 16% after NP with above-normal ambulatory BP monitoring (P<0.001). Other cardiovascular risk markers more common 2 years post-preeclampsia included higher body mass index (median 26.6 versus 23.1, P=0.003) and insulin resistance.CONCLUSIONSAfter preeclampsia, women have significantly higher BP 6 months and 2 years postpartum, and have higher body mass index and insulin-resistance scores, increasing their future cardiovascular risk. Regular cardiovascular risk screening should be implemented for all who have experienced preeclampsia.
Author Pettit, Franziska
Youssef, George
Mangos, George
Crowley, Rose
Henry, Amanda
Brown, Mark A
Roberts, Lynne M
Davis, Gregory K
O'Sullivan, Anthony J
Author_xml – sequence: 1
  givenname: Amanda
  orcidid: 0000-0002-7351-8922
  surname: Henry
  fullname: Henry, Amanda
  organization: Departments of Women's and Children's Health (A.H., L.M.R., G.K.D.)
– sequence: 2
  givenname: George
  surname: Mangos
  fullname: Mangos, George
  organization: Departments of Renal Medicine (G.M., M.A.B., F.P.)
– sequence: 3
  givenname: Lynne M
  orcidid: 0000-0003-2339-3751
  surname: Roberts
  fullname: Roberts, Lynne M
  organization: Departments of Women's and Children's Health (A.H., L.M.R., G.K.D.)
– sequence: 4
  givenname: Mark A
  orcidid: 0000-0002-4759-9407
  surname: Brown
  fullname: Brown, Mark A
  organization: Departments of Renal Medicine (G.M., M.A.B., F.P.)
– sequence: 5
  givenname: Franziska
  surname: Pettit
  fullname: Pettit, Franziska
  organization: Departments of Renal Medicine (G.M., M.A.B., F.P.)
– sequence: 6
  givenname: Anthony J
  surname: O'Sullivan
  fullname: O'Sullivan, Anthony J
  organization: Endocrinology (A.J.O.), St George Hospital, Kogarah, Australia
– sequence: 7
  givenname: Rose
  surname: Crowley
  fullname: Crowley, Rose
  organization: Cardiology (R.C., G.Y.) St George Hospital, Sydney, Australia
– sequence: 8
  givenname: George
  orcidid: 0000-0003-0579-1975
  surname: Youssef
  fullname: Youssef, George
  organization: Cardiology (R.C., G.Y.) St George Hospital, Sydney, Australia
– sequence: 9
  givenname: Gregory K
  surname: Davis
  fullname: Davis, Gregory K
  organization: Departments of Women's and Children's Health (A.H., L.M.R., G.K.D.)
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38288610$$D View this record in MEDLINE/PubMed
BookMark eNpdkV9P2zAUxS3ENArsKyDzxks6X9tx7L2gqCorEoMKOmk8Wa7j0IzULnaC1G-_jH8Cnq507znnHum3j3Z98A6hYyBjAAHfZ7fz6fVienlzfnVZzsoxUDamIBXZQSPIKc94LtguGhFQPFMAf_bQfkp_CQHOefEV7TFJpRRARqieR-dsa9ab1JisTCnYxnSuwhMTqyY8mmT71kR83aR7fGZsF2LCAv8KvlslbHyFKb51ZliWdeciHuLuvPF2-wMvVg7POb7p-mp7iL7Upk3u28s8QL_PpovJLLu4-nk-KS8yy4TsMiictapSBSkogUJwamuwwrKCCFmrJZVWcgtOWgWkEnluWC5zxlmtilwuDTtAp8-5m365dpV1voum1ZvYrE3c6mAa_fHim5W-C48aiMqFEHxIOHlJiOGhd6nT6yZZ17bGu9AnTdXQTAolikGqnqU2hpSiq9_-ANH_QelPoPQASj-BGrxH74u-OV_JsH_f5ZLZ
Cites_doi 10.1161/HYP.0000000000000087
10.1186/s12905-021-01524-w
10.1161/JAHA.120.018604
10.1161/CIR.0b013e31820faaf8
10.1186/s13098-015-0085-5
10.3389/fcvm.2019.00160
10.1089/jwh.2018.7523
10.1111/1471-0528.15394
10.1210/clinem/dgab223
10.1016/j.preghy.2019.08.088
10.1016/j.atherosclerosis.2015.01.027
10.1016/j.preghy.2018.05.004
10.1161/HYPERTENSIONAHA.120.17101
10.1161/JAHA.122.028116
10.1016/j.preghy.2016.08.241
10.1161/CIRCULATIONAHA.118.038080
10.1093/eurheartj/ehy339
10.1016/j.preghy.2020.07.001
10.1371/journal.pmed.1002875
10.1161/HYPERTENSIONAHA.120.14971
10.1016/j.jacc.2017.11.006
10.1111/1471-0528.17381
10.1161/HYPERTENSIONAHA.120.15875
10.1007/s12020-016-1075-6
10.1177/2047487319879791
10.1097/AOG.0000000000002633
10.1161/HYPERTENSIONAHA.111.176537
10.1016/j.atherosclerosis.2019.11.023
10.1016/j.preghy.2021.09.008
10.1161/CIRCOUTCOMES.116.003497
10.1016/j.preghy.2021.10.004
10.1136/heartjnl-2020-316541
10.1136/bmj.i2416
10.1136/bmj.39335.385301.BE
ContentType Journal Article
Copyright 2024 The Authors. 2024
Copyright_xml – notice: 2024 The Authors. 2024
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
DOI 10.1161/HYPERTENSIONAHA.123.21890
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList CrossRef
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1524-4563
EndPage 860
ExternalDocumentID 10_1161_HYPERTENSIONAHA_123_21890
38288610
Genre Journal Article
GroupedDBID ---
.-D
.3C
.55
.GJ
.XZ
.Z2
01R
0R~
18M
1J1
2WC
3O-
40H
4Q1
4Q2
4Q3
53G
5GY
5RE
5VS
71W
77Y
7O~
AAAAV
AAAXR
AAFWJ
AAGIX
AAHPQ
AAIQE
AAJCS
AAMOA
AAMTA
AAQKA
AARTV
AASCR
AASOK
AAXQO
AAYEP
ABASU
ABBUW
ABDIG
ABJNI
ABOCM
ABQRW
ABVCZ
ABXVJ
ABZAD
ACCJW
ACDDN
ACEWG
ACGFO
ACGFS
ACILI
ACLDA
ACWDW
ACWRI
ACXJB
ACXNZ
ADBBV
ADFPA
ADGGA
ADHPY
ADNKB
AE3
AE6
AEBDS
AEETU
AENEX
AFDTB
AFEXH
AFFNX
AFUWQ
AGINI
AHMBA
AHOMT
AHQNM
AHRYX
AHVBC
AIJEX
AINUH
AJIOK
AJNWD
AJNYG
AJZMW
AKULP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AWKKM
BAWUL
BCGUY
BOYCO
BQLVK
BS7
C1A
C45
CGR
CS3
CUY
CVF
DIK
DIWNM
DUNZO
E.X
E3Z
EBS
ECM
EEVPB
EIF
EJD
ERAAH
EX3
F2K
F2L
F2M
F2N
F5P
FCALG
FL-
FW0
GNXGY
GQDEL
GX1
H0~
H13
HLJTE
HZ~
IKREB
IKYAY
IN~
IPNFZ
JF9
JG8
JK3
JK8
K-A
K-F
K8S
KD2
KMI
KQ8
L-C
L7B
N4W
N9A
NPM
N~7
N~B
N~M
O9-
OAG
OAH
OB3
OCUKA
ODA
ODMTH
OGROG
OHYEH
OK1
OL1
OLG
OLH
OLU
OLV
OLW
OLY
OLZ
OPUJH
ORVUJ
OUVQU
OVD
OVDNE
OVIDH
OVLEI
OWBYB
OWU
OWV
OWW
OWX
OWY
OWZ
OXXIT
P-K
P2P
PQQKQ
R58
RAH
RHF
RIG
RLZ
S4R
S4S
T8P
TEORI
TR2
TSPGW
V2I
VVN
W3M
W8F
WH7
WOQ
WOW
X3V
X3W
X7M
XXN
XYM
YFH
YHZ
YOC
YYM
YYP
ZFV
ZGI
ZZMQN
AAYXX
CITATION
7X8
5PM
ID FETCH-LOGICAL-c368t-17ecc9d97072017642cf1c6c37068f9b28c84c1e8c910d655a3585343f9758ba3
ISSN 0194-911X
IngestDate Tue Sep 17 21:29:03 EDT 2024
Sat Oct 26 06:08:39 EDT 2024
Fri Aug 23 01:28:02 EDT 2024
Tue Oct 29 09:18:11 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords risk factors
pre-eclampsia
cardiovascular diseases
postpartum period
hypertension
longitudinal studies
Language English
License Hypertension is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution Non-Commercial-NoDerivs License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited, the use is noncommercial, and no modifications or adaptations are made.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c368t-17ecc9d97072017642cf1c6c37068f9b28c84c1e8c910d655a3585343f9758ba3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-4759-9407
0000-0003-0579-1975
0000-0002-7351-8922
0000-0003-2339-3751
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC10956664
PMID 38288610
PQID 2920186967
PQPubID 23479
PageCount 10
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_10956664
proquest_miscellaneous_2920186967
crossref_primary_10_1161_HYPERTENSIONAHA_123_21890
pubmed_primary_38288610
PublicationCentury 2000
PublicationDate 2024-04-01
PublicationDateYYYYMMDD 2024-04-01
PublicationDate_xml – month: 04
  year: 2024
  text: 2024-04-01
  day: 01
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Hagerstown, MD
PublicationTitle Hypertension (Dallas, Tex. 1979)
PublicationTitleAlternate Hypertension
PublicationYear 2024
Publisher Lippincott Williams & Wilkins
Publisher_xml – name: Lippincott Williams & Wilkins
References e_1_3_3_17_2
e_1_3_3_16_2
e_1_3_3_19_2
e_1_3_3_18_2
e_1_3_3_13_2
e_1_3_3_12_2
e_1_3_3_15_2
e_1_3_3_34_2
e_1_3_3_14_2
e_1_3_3_35_2
e_1_3_3_32_2
e_1_3_3_33_2
e_1_3_3_11_2
e_1_3_3_30_2
e_1_3_3_10_2
e_1_3_3_31_2
e_1_3_3_6_2
e_1_3_3_5_2
e_1_3_3_8_2
e_1_3_3_7_2
e_1_3_3_28_2
e_1_3_3_9_2
e_1_3_3_27_2
e_1_3_3_29_2
e_1_3_3_24_2
e_1_3_3_23_2
e_1_3_3_26_2
e_1_3_3_25_2
e_1_3_3_2_2
e_1_3_3_20_2
e_1_3_3_4_2
e_1_3_3_22_2
e_1_3_3_3_2
e_1_3_3_21_2
References_xml – ident: e_1_3_3_17_2
  doi: 10.1161/HYP.0000000000000087
– ident: e_1_3_3_29_2
  doi: 10.1186/s12905-021-01524-w
– ident: e_1_3_3_13_2
  doi: 10.1161/JAHA.120.018604
– ident: e_1_3_3_22_2
  doi: 10.1161/CIR.0b013e31820faaf8
– ident: e_1_3_3_18_2
  doi: 10.1186/s13098-015-0085-5
– ident: e_1_3_3_30_2
  doi: 10.3389/fcvm.2019.00160
– ident: e_1_3_3_31_2
  doi: 10.1089/jwh.2018.7523
– ident: e_1_3_3_9_2
  doi: 10.1111/1471-0528.15394
– ident: e_1_3_3_14_2
  doi: 10.1210/clinem/dgab223
– ident: e_1_3_3_26_2
  doi: 10.1016/j.preghy.2019.08.088
– ident: e_1_3_3_8_2
  doi: 10.1016/j.atherosclerosis.2015.01.027
– ident: e_1_3_3_15_2
  doi: 10.1016/j.preghy.2018.05.004
– ident: e_1_3_3_34_2
  doi: 10.1161/HYPERTENSIONAHA.120.17101
– ident: e_1_3_3_27_2
  doi: 10.1161/JAHA.122.028116
– ident: e_1_3_3_12_2
  doi: 10.1016/j.preghy.2016.08.241
– ident: e_1_3_3_5_2
  doi: 10.1161/CIRCULATIONAHA.118.038080
– ident: e_1_3_3_20_2
  doi: 10.1093/eurheartj/ehy339
– ident: e_1_3_3_33_2
  doi: 10.1016/j.preghy.2020.07.001
– ident: e_1_3_3_4_2
  doi: 10.1371/journal.pmed.1002875
– ident: e_1_3_3_28_2
  doi: 10.1161/HYPERTENSIONAHA.120.14971
– ident: e_1_3_3_19_2
  doi: 10.1016/j.jacc.2017.11.006
– ident: e_1_3_3_32_2
  doi: 10.1111/1471-0528.17381
– ident: e_1_3_3_35_2
  doi: 10.1161/HYPERTENSIONAHA.120.15875
– ident: e_1_3_3_7_2
  doi: 10.1007/s12020-016-1075-6
– ident: e_1_3_3_10_2
  doi: 10.1177/2047487319879791
– ident: e_1_3_3_23_2
  doi: 10.1097/AOG.0000000000002633
– ident: e_1_3_3_24_2
  doi: 10.1161/HYPERTENSIONAHA.111.176537
– ident: e_1_3_3_25_2
  doi: 10.1016/j.atherosclerosis.2019.11.023
– ident: e_1_3_3_2_2
  doi: 10.1016/j.preghy.2021.09.008
– ident: e_1_3_3_3_2
  doi: 10.1161/CIRCOUTCOMES.116.003497
– ident: e_1_3_3_16_2
  doi: 10.1016/j.preghy.2021.10.004
– ident: e_1_3_3_6_2
  doi: 10.1136/heartjnl-2020-316541
– ident: e_1_3_3_11_2
  doi: 10.1136/bmj.i2416
– ident: e_1_3_3_21_2
  doi: 10.1136/bmj.39335.385301.BE
SSID ssj0014447
Score 2.499269
Snippet Increased cardiovascular risk following preeclampsia is well established and there are signs of early cardiovascular aging 6 months postpartum. This study...
BACKGROUND: Increased cardiovascular risk following preeclampsia is well established and there are signs of early cardiovascular aging 6 months postpartum....
BACKGROUNDIncreased cardiovascular risk following preeclampsia is well established and there are signs of early cardiovascular aging 6 months postpartum. This...
SourceID pubmedcentral
proquest
crossref
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 851
SubjectTerms Blood Pressure - physiology
Cardiovascular Diseases - diagnosis
Cardiovascular Diseases - epidemiology
Cardiovascular Diseases - etiology
Cross-Sectional Studies
Female
Heart Disease Risk Factors
Humans
Hypertension - diagnosis
Original
Pre-Eclampsia - diagnosis
Pre-Eclampsia - epidemiology
Pregnancy
Risk Factors
Title Preeclampsia-Associated Cardiovascular Risk Factors 6 Months and 2 Years After Pregnancy: The P4 Study
URI https://www.ncbi.nlm.nih.gov/pubmed/38288610
https://search.proquest.com/docview/2920186967
https://pubmed.ncbi.nlm.nih.gov/PMC10956664
Volume 81
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6FIlVcEG_CS1uJm-UQe9frXW4RtLKAVAG1Unqy7PW67QGnykOi_DX-HDPrjWMnVEAvVmRbK8fzeV77zQwhb6NhUYpcKKzoySFAybmvuDK-ycsg42Uescx2-zwWySn_NI2mvd6vFmtptcwH-ucf60puI1U4B3LFKtn_kGyzKJyA3yBfOIKE4fhPMp7MjdEg0qvFZeavXzSmbLsk029IHz9yg3UEfsbLi7o1c-idAdIX3shOCoflzrH_xvWaijHhlmfY2flNIHCdW9q7xY38iJn4mmtkfgy8QMWqlV1oaiBG37NW8D_OqvNZKye_2fZBnre98OUaLIA3HuzkC7C6yBsN2umKsM1ycRlMxVHDTmsD5LQu3AeeHGurZRm04MdbOla6DrXOXNfjCHYtgUBLkJxNDiEuOEbDNEow88sG4NTUE0q73be3rGLDVbRRkgjSraVSWCq1S90hd0PQcsgn_Px1s4XFOXe1-vX_3ScH7rne3fhUXedoJ-LZJu62PKGTB-S-C2HoqMbjQ9Iz1SOyP3YkjcekvAGWtAtLirCkDpZU0BqWFGBCQ2phSS0saQPL9xRASSecWlA-IadHhycfEt-N8_A1E3LpBzGoC1WoeBiD1xlD4KvLQAvN4qGQpcpDqSXXgZEaXNhCRFHGIJZlnJUKgto8Y0_JXjWrzHNCjYkxmVLGBbinpZJYf10MNcQOrGBK6z4J1-8xvaq7tqR_lWOfHKzfeAo6FjfOssrMVosUJ7rh6DYR98mzWgLNskyGUkIM0ieyI5vmBuzf3r1SXV7YPu4BNgEVgr-4zdO-JPc2n9crsrecr8xr8I-X-RuLw9_6KrQI
link.rule.ids 230,315,783,787,888,27938,27939
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Preeclampsia-Associated+Cardiovascular+Risk+Factors+6+Months+and+2+Years+After+Pregnancy%3A+The+P4+Study&rft.jtitle=Hypertension+%28Dallas%2C+Tex.+1979%29&rft.au=Henry%2C+Amanda&rft.au=Mangos%2C+George&rft.au=Roberts%2C+Lynne+M.&rft.au=Brown%2C+Mark+A.&rft.date=2024-04-01&rft.issn=0194-911X&rft.eissn=1524-4563&rft.volume=81&rft.issue=4&rft.spage=851&rft.epage=860&rft_id=info:doi/10.1161%2FHYPERTENSIONAHA.123.21890&rft.externalDBID=n%2Fa&rft.externalDocID=10_1161_HYPERTENSIONAHA_123_21890
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0194-911X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0194-911X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0194-911X&client=summon